Skip to main content
Fig. 8 | BMC Urology

Fig. 8

From: Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma

Fig. 8

Immunological landscape in BLCA patients and relationship between TMB and risk scores. (A) Heatmap of the tumor-infiltrating lymphocytes among two groups in BLCA. (B-C) Analysis of TMB differences and TIDE prediction score. (D-E) Waterfall plot of top 15 mutation genes in the high-risk and low-risk group in BLCA. (F) Overall survival analysis curves of the high- and low-TMB groups. (G) Overall survival curve combined with TMB risk in BLCA. TMB, tumor mutation burden; TIDE, tumor immune dysfunction and exclusion; BLCA, bladder urothelial carcinoma

Back to article page